Spinal Tech

Celling Spine, a subsidiary of Celling Biosciences, acquired all assets of Link Spine, which is a subsidiary of Link Orthopedics.

Smith & Nephew completed the acquisition of Atracsys Sàrl, a Switzerland-based provider of optical tracking technology used in computer-assisted surgery.

Saluda Medical acquired $75 million in equity financing from Boston Scientific and Redmile Group to fund the finishing stages of its Evoke evoked action compound potential-controlled, Closed-Loop Spinal Cord Stimulation System.

Fusion Robotics closed its financing round for an undisclosed figure with lead investment by Alex Lukianov of Lukpartners and Kevin Foley, MD.

Alexion Pharmaceuticals' Soliris received FDA approval for the treatment of neuromyelitis optica spectrum disorder in adult patients who test positive for the anti-aquaporin-4 antibody.

Globus Medical appointed Keith Pfeil as senior vice president and CFO, effective August 19.

Joint replacement implant device company MicroPort Orthopedics launched its Evolution NitrX Medial-Pivot Knee System.

Saluda Medical agreed a four-year loan with Medtronic to develop its Evoke evoked action compound potential-controlled, Closed-Loop Spinal Cord Stimulation System for the treatment of chronic intractable pain of the trunk and limbs.

Zeeshan Sardar, MD, is an orthopedic surgeon specializing in spine at NewYork-Presbyterian Och Spine Hospital in New York City. Here, Dr. Sardar provides four key issues to consider when adapting a new spine device.

Partner Orthopedics closed its Series B financing round led by Medeon Biodesign and expanded clinical use of its flexible fixation device, the PUMA System.